Rezension:
I\'d like to apply for this job prolatis recall Celgene Corp, up 7 percent to $133.86, was amongthe top performers for both the S&P 500 and the Nasdaq 100 after the company said a late-stage trial of its cancerdrug Revlimid met the main goal of improving survival in newlydiagnosed blood cancer patients.
